Regulatory agencies are continuously updating guidelines for diabetes management, including recommendations regarding the use of GLP-1 agonists, which influence prescribing practices and market penetration
Although they will always encourage patients to get full and appropriate medical consultation, that doesnt always happen
doi: 10.1093/eurheartj/ehad736 16 GuptaVWaliaGKSachdevaMP
These include direct inhibition of inflammasome components, caspase-1 blockade, modulation of immune responses using anti-inflammatory agents, and targeted manipulation of gut microbiota and bile acid metabolism, which are increasingly recognized for their roles in liver homeostasis and injury response
This game-changing therapy is helping patients lose weight consistently, improve energy, and regain control of their health through an easy-to-follow, weekly injection protocol
Abstract Background and Objective This systematic review and meta-analysis aimed to evaluate the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the management of knee osteoarthritis (KOA), particularly in relation to weight reduction, pain relief, and functional improvement